Showing results (241-250 of 286) with videos related to
Sort By:
Pageof 29
Japanese Journal of Clinical Oncology|October 7, 2024
Prognostic risk score and index including the platelet-to-lymphocyte ratio and lactate dehydrogenase in patients with metastatic or unresectable urothelial carcinoma treated with immune checkpoint inhibitorsKeita Kobayashi, Shigeru Sakano, Hiroaki Matsumoto, et al.Communications Biology|June 25, 2021
TGF-β-dependent reprogramming of amino acid metabolism induces epithelial-mesenchymal transition in non-small cell lung cancersFumie Nakasuka, Sho Tabata, Takeharu Sakamoto, et al.Lung Cancer (Amsterdam, Netherlands)|January 17, 2026
Prognostic value of preoperative ctDNA and pathological venous invasion for recurrence in EGFR-mutated non-small cell lung cancerYuya Murase, Hayato Koba, Hideharu Kimura, et al.The Prostate|July 21, 2025
Refining the CHAARTED Classification: Clinical Utility of a Novel Integrated Risk Stratification Model Incorporating Gleason Grade and Biochemical Markers in Japanese Patients With Metastatic Hormone-Sensitive Prostate CancerTakanori Tokunaga, Keita Kobayashi, Kazuhiro Nagao, et al.Developmental Cell|February 3, 2024
Astrocyte-induced mGluR1 activates human lung cancer brain metastasis via glutamate-dependent stabilization of EGFRKojiro Ishibashi, Toshiya Ichinose, Riki Kadokawa, et al.Cancer Letters|July 26, 2024
Triple combination therapy comprising osimertinib, an AXL inhibitor, and an FGFR inhibitor improves the efficacy of EGFR-mutated non-small cell lung cancerRyota Nakamura, Tadaaki Yamada, Shinsaku Tokuda, et al.Respiratory Medicine|January 2, 2026
Anti-MDA5 Antibody-Positive Interstitial Lung Disease without Prominent Skin or Muscle Manifestations: A High-Risk and Potentially Overlooked SubgroupAtsushi Muto, Satoshi Watanabe, Yuko Waseda, et al.Molecular Cancer Therapeutics|December 14, 2002
Targeted therapy against human lung cancer in nude mice by high-affinity recombinant antimesothelin single-chain Fv immunotoxinDominic Fan, Seiji Yano, Hisashi Shinohara, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 15, 2025
Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung CancerKoji Fukuda, Shigeki Nanjo, Shinji Takeuchi, et al.Cancer Science|November 9, 2025
MET Enhances Amivantamab Binding to EGFR and Antibody-Dependent Cellular ToxicityShigeki Sato, Neval Yilmaz, Sachiko Arai, et al.Pageof 29